CAS 130775-79-0

Methanone,[(5R)-4,5-dihydro-5-methyl-1H-pyrazol-1-yl]-3-pyridinyl-

Description:

Methanone, [(5R)-4,5-dihydro-5-methyl-1H-pyrazol-1-yl]-3-pyridinyl- is a chemical compound characterized by its unique structural features, which include a pyrazole ring and a pyridine moiety. The presence of the dihydro-pyrazole structure indicates that it has a saturated five-membered ring, contributing to its stability and reactivity. The methyl group on the pyrazole enhances its hydrophobic character, while the pyridine ring introduces basicity due to the nitrogen atom, which can participate in hydrogen bonding and coordination with metal ions. This compound may exhibit biological activity, potentially acting as a ligand or a pharmacophore in medicinal chemistry. Its molecular interactions are influenced by the functional groups present, which can affect solubility, permeability, and overall bioactivity. The CAS number 130775-79-0 serves as a unique identifier for this compound, facilitating its identification in chemical databases and literature. Overall, this substance's characteristics make it of interest in various fields, including pharmaceuticals and agrochemicals.

Formula: C₁₀H₁₁N₃O

Synonyms:

• 1H-Pyrazole,4,5-dihydro-5-methyl-1-(3-pyridinylcarbonyl)-, (5R)- (9CI)
• 1H-Pyrazole, 4,5-dihydro-5-methyl-1-(3-pyridinylcarbonyl)-,(R)-
• (-)-1-(3-Pyridylcarbonyl)-5-methyl-2-pyrazoline
• Ms 153

(R)-(5-Methyl-4,5-dihydro-1H-pyrazol-1-yl)(pyridin-3-yl)methanone

CAS: 130775-79-0

Formula: C₁₀H₁₁N₃O

Molecular weight: 189.2138

Ref: IN-DA00HS99

MS 153

CAS: 130775-79-0

MS 153 is a compound that has been shown to have an inhibitory effect on chronic exposure in animals. It has also been shown to attenuate the effects of gamma-aminobutyric acid (GABA) in the blood sample and to reduce locomotor activity. MS 153 has a high affinity for GABA receptors and glutamate, which are neurotransmitters that play an important role in regulating many bodily functions. MS 153 also inhibits glutamate release from nerve terminals, suggesting that this drug could be used as an anti-seizure medication. The uptake of MS 153 into the brain is mediated by both extracellular and expressed mechanisms. It is transported across the blood-brain barrier by an active transport process, as well as by passive diffusion. The uptake of MS 153 into neurons is dependent on the concentration gradient, with a higher concentration gradient leading to increased uptake. The spatial distribution of MS 153 in the brain was investigated using high resolution magnetic resonance spectroscopy (HRMS). This study revealed that

Formula: C₁₀H₁₁N₃O

Purity: Min. 95%

Color and Shape: Powder

Molecular weight: 189.21 g/mol

Ref: 3D-FFA77579

(R)-(5-METHYL-4,5-DIHYDRO-1H-PYRAZOL-1-YL)(PYRIDIN-3-YL)METHANONE

CAS: 130775-79-0

Formula: C₁₀H₁₁N₃O

Purity: 97.0%

Color and Shape: Solid

Molecular weight: 189.218

Ref: 10-F301982